If you have spent any time researching skin rejuvenation treatments lately, you have probably noticed that two names keep coming up together: polynucleotides and PDRN. Both are derived from salmon DNA. Both are described as regenerative. Both are being used in aesthetic clinics around the world. So it is completely reasonable to assume they are basically the same thing with different packaging.
They are not.
The molecular difference between polynucleotides (PN) and polydeoxyribonucleotide (PDRN) is real, clinically meaningful, and it directly affects the results you can expect from your treatment. At VBeauty Medical Spa in Yorkville, Toronto, we think that distinction is worth understanding before you book anything. So here is a clear breakdown of how they compare, why PN consistently comes out ahead for aesthetic purposes, and how getting this treatment right from the start can amplify everything else you do for your skin.
They Both Start With Salmon. Here Is Where They Diverge.
Polynucleotides and PDRN share the same origin story. Both are extracted from purified salmon sperm DNA, which has a molecular compatibility with human tissue that makes it well-suited for injectable use. That shared origin is why clinics and patients often treat them as interchangeable. But the processing is where the two compounds go in entirely different directions.
Polynucleotides are long-chain DNA fragments. Because they are larger molecules, they retain a more complete biological signalling capacity. When injected into skin tissue, those long chains interact with receptors in a way that triggers a broad and coordinated regenerative response.
PDRN is produced through a different process called a salvage pathway. This produces shorter DNA fragments with a lower molecular weight. The receptor interaction is different, the downstream signalling is different, and critically, the evidence base built around the two compounds is very different. Presentations at the AMWC medical aesthetics congress have been explicit on this point: PN has Level 1 clinical data in aesthetics. PDRN does not. They are not interchangeable in clinical claims, and they should not be treated as equivalent in a treatment plan.
How Polynucleotides Work: Cell Activators, Not Just Hydrators
The term that best describes what polynucleotides do in the skin is cell activator. This is an important distinction from the language typically used to describe skin boosters, which tends to focus on hydration, plumping, or filling. PN does something more fundamental than that.
When polynucleotides are injected, they activate the A2A adenosine receptor. That activation sets off a cascade of anti-inflammatory and pro-angiogenic signalling throughout the dermis. In practical terms, this means:
- Collagen synthesis is upregulated
- Skin elasticity improves as the extracellular matrix remodels
- Fibroblasts, the cells responsible for producing collagen and elastin, are directly stimulated
- Dermal hydration increases through improved tissue architecture, not simply water attraction
- Inflammation is actively reduced, which supports healthier, more resilient skin over time
PDRN works through the ERK1/2 pathway, which supports fibroblast proliferation and DNA repair via deoxyribonucleotide recycling. This is biologically rational and the safety profile is good. However, the aesthetic-specific clinical trial data for PDRN is largely absent. Most of what exists has been extrapolated from wound care and orthopaedic literature. For skin rejuvenation, that gap matters.
The short version: both compounds do something useful. But PN has the clinical evidence in aesthetics to back it up, and its mechanism produces a more comprehensive skin response.
Not One Product Fits Every Area: PN Formulations by Facial Zone
One of the most important things to understand about polynucleotide treatments is that they are not one protocol. The concentration, molecular weight, and carrier ingredients in a PN product can vary considerably, and those differences matter depending on which area of the face is being treated.
Selecting the right formulation for the right zone is a clinical decision, not a product preference. Here is how the logic breaks down by area:
Under Eyes
The periorbital area is the most delicate skin on the face. It is thinner, more vascular, and highly prone to showing the Tyndall effect or oedema if the wrong product is used. PN formulations designed for under-eye use are lighter, lower in concentration, and prioritize tissue remodelling over volume. This makes them one of the most effective treatments available for crepiness, fine lines, and skin quality in the tear trough area, used strategically alongside any structural correction.
Mid Face and Cheeks
Medium-concentration PN protocols in the mid face focus on collagen stimulation, elasticity restoration, and improved skin density. This is an area where the cumulative, progressive nature of PN really shows: results continue to build over the weeks following treatment as fibroblast activity sustains the remodelling process.
Full Face and Overall Skin Quality
Higher concentration protocols addressing the full face target texture, pore refinement, tone, and early laxity. These are often the most appropriate starting point for patients new to polynucleotide treatment, as they establish a strong cellular foundation before more targeted work begins.
Neck and Decolletage
Thinner, more photodamaged tissue in the neck and chest requires formulations specifically suited to these characteristics. The goal here is structural repair and improved skin quality rather than volume, and PN is one of the few treatments with a genuine regenerative mechanism to support both.
A Note on Products You May Have Seen Referenced
If you have been researching PN treatments, you have likely come across a number of brand names. Each has distinct formulation characteristics worth knowing about:
- Plinest (also known as Newest): one of the most studied PN products in aesthetics, with specific formulations for the face and periorbital area
Rejuran: a Korean-origin PN product collected via DNA Optimizing Technology, known particularly for skin healing, texture improvement, and a strong clinical track record
- Vamp: a newer-generation formulation combining polynucleotides with other regenerative actives
Nucleofill: an Italian PN product with multiple molecular weight options designed for different facial zones and tissue depths
NucleoSkin: the formulation used at VBeauty Medical Spa, which combines polynucleotides with hyaluronic acid and glutathione for simultaneous remodelling, plumping, and brightening
- Julapro: a Korean PN product gaining recognition in international aesthetic medicine circles
These products are not identical, and substituting one for another without understanding the formulation differences is how results become inconsistent. At VBeauty, product selection is part of the consultation process.
Why Polynucleotides Make Every Other Treatment Work Better
Here is something that does not get discussed enough: polynucleotides are not just a standalone treatment. Used strategically, they function as a primer that amplifies the results of almost any other aesthetic procedure you combine them with. The mechanism is straightforward. When skin cells are already in an active state of regeneration and repair, they respond more efficiently to any additional stimulus you introduce.
Before Laser Treatments: IPL and CO2
Laser treatments like Lumecca IPL and CO2 + Erbium laser resurfacing work by delivering controlled thermal energy to stimulate the skin’s healing response. The quality of that healing response depends directly on the cellular environment it happens in. Skin that has been primed with polynucleotides goes into a laser treatment with upregulated fibroblasts, improved tissue vascularity, and a more organized extracellular matrix. The result is a faster recovery, reduced post-treatment inflammation, and a more robust collagen remodelling response compared to laser on unprepared skin.
For ablative treatments like CO2 laser in particular, this preparation is genuinely meaningful. The skin is being asked to do significant repair work. Giving it the cellular tools to do that work more efficiently is not a minor upgrade. We covered this combination in detail in our article on CO2 laser, salmon DNA, and exosome treatments if you want to go deeper on the science.
Before Biostimulants: Sculptra and Radiesse
Sculptra (poly-L-lactic acid) and Radiesse (calcium hydroxylapatite) are both collagen-stimulating biostimulants that work progressively over time. Sculptra gradually triggers the body to produce new collagen, while Radiesse acts as both an immediate volumizer and a long-term biostimulant.
Pre-treating with polynucleotides before either of these enhances the tissue environment that receives the biostimulant. Better-primed fibroblasts, improved tissue vascularity, and a reduced inflammatory baseline mean the biostimulant has a more organized, responsive tissue bed to work in. Think of it as preparing the soil before planting. The seed is the same either way, but what you grow from it is considerably different.
Victoria, RN, BScN, MScN, regularly incorporates PN as a preparatory step in combination treatment plans at VBeauty for exactly this reason. When patients come in for Sculptra or Radiesse, the question is not just what to inject but in what condition the skin should be when it receives those treatments.
Before Microneedling, RF Treatments, Peels, and Thread Lifts
The same principle applies across the board. Polynucleotides as a cell-activating primer create a biological state that makes skin more receptive to any treatment that asks the tissue to repair or remodel, including Morpheus8 RF microneedling, chemical peels, and thread lifting. This is not a trend claim. It is a mechanistic one rooted in how regenerative signalling pathways work.
Why Combination Treatment Is Almost Always the Better Answer
Polynucleotides address tissue quality with precision: collagen density, elasticity, hydration, and cellular health. What they do not replace is structural volume, targeted pigmentation correction, or the vascular component of certain concerns. That is why combination treatment consistently produces better outcomes than any single protocol.
The under-eye area is the clearest example. Dark circles and hollowing under the eyes involve at least three separate issues: thin, crepey skin quality, volume loss in the tear trough, and in many cases a vascular or pigmentation component contributing to discolouration. Polynucleotides are outstanding for the skin quality and tissue remodelling component. But a comprehensive result for the under-eye area typically also involves a conservative approach to structural support with a light hyaluronic acid filler, and in some cases, adjunctive treatments for vascular pigmentation. No single product does all of that.
Other strong combination pairings worth knowing about:
PN and Morpheus8 radiofrequency for skin laxity: PN rebuilds the tissue while RF tightens it
PN and CO2 laser for acne scarring and texture: PN prepares and accelerates healing, CO2 laser resurfaces
PN and Sculptra for full-face volume restoration with skin quality improvement
PN and thread lifts for patients who want structural repositioning alongside regenerative improvement
PN and Profhilo bioremodelling for patients seeking deep hydration layered on top of cellular regeneration
The right combination for any individual depends on what their skin actually needs, which is a conversation that belongs in a consultation room, not a product menu.
A Fair Word on PDRN
None of this is to say that PDRN has no place in aesthetic medicine. It is biologically rational, has a good safety profile, and has emerging data in certain skin applications. Its evidence base in wound healing is well-established, and there is ongoing research into its aesthetic potential.
The problem is not PDRN itself. The problem is when PDRN products are positioned as equivalent to PN for aesthetic use, because the current evidence does not support that positioning. If a clinic is offering PDRN as a like-for-like alternative to polynucleotide treatment, that is a reasonable moment to ask which clinical literature they are drawing on to make that comparison.
The guidance from international aesthetic congresses is consistent: PN has Level 1 aesthetic evidence. PDRN currently does not. Until that changes, treating them as interchangeable misrepresents what the science actually shows.
The Right Treatment Starts With the Right Conversation
Polynucleotides are not a one-size-fits-all treatment, and they are not a standalone solution for every skin concern. The product, the concentration, the facial zone, the combination protocol, and the sequencing of treatments all matter. If you want a full picture of what PN can do on its own, our polynucleotides treatment page is a good starting point. Getting those decisions right is the difference between a good result and a great one.
Victoria, RN, BScN, MScN, works with each patient at VBeauty Medical Spa to build a treatment plan grounded in your skin’s actual condition and your actual goals, not a generic protocol. If you are curious about polynucleotide treatment, whether as a starting point or as part of a combination approach alongside CO2 laser, Sculptra, or Radiesse, a consultation is the place to start.
Book your free consultation at VBeauty Medical Spa in Yorkville, Toronto.
182 Davenport Rd., Toronto, ON M5R 1J2 | vbeautyspa.com | 416-839-1771
